A Novel Liquid Crystal Drug Delivery for Transdermal Application
DOI:
https://doi.org/10.37591/tdd.v2i2.278Abstract
The present study was aimed at the formulation of liquid crystals of acyclovir that will be incorporated into a transdermal patch. Liquid crystals serve as drug carrier and have a good penetration-enhancer property, due to the extensive similarity of these colloidal systems with the intercellular lipids in the stratum corneum. The liquid crystals were prepared using tween 80 as emulsifier, cetosteryl alcohol as emulsion stabilizer and double-distilled water. Liquid crystals were evaluated for viscosity, entrapment efficiency, SEM and in vitro drug release studies. Formulation LC21 was found to be the best on the basis of the parameters evaluated and hence was selected for incorporation into the transdermal patches. Transdermal patches were prepared using Na CMC, HPMC 50 cps, HPMC E 15 LV and HPMC K4M and were evaluated for in vitro permeation, tensile strength, percent moisture absorption, in vivo studies in rat model for skin irritation. All the patches showed extended release properties. Formulation F6 was found to be the optimized formulation on the basis of evaluation parameters. In vitro permeation release was found to be 81.13% at the end of 24th hour. The release kinetics of the transdermal patches followed Korsmeyer-Peppas model. The patches were found to be stable. Skin irritation studies on rats showed that the prepared patches were compatible. Based on the encouraging results, the transdermal patches containing acyclovir loaded liquid crystals can be used as extended release system.
Keywords: Acyclovir, liquid crystals, transdermal patch
Cite this Article
Charyulu R Narayana, Deshprabhu Nirmal, Dixit Mudit. A novel liquid crystal drug delivery for transdermal application. Trends in Drug Delivery. 2015; 2(2): 28–37p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |